The drugs are called HDAC inhibitors, and the investigators have early evidence one can reactivate after birth the gene that produces fetal hemoglobin, which cannot sickle.
Betty Pace, MD, is the recipient of the American Medical Women’s Association’s 2023 Woman in Science Award.